Close

RXi Pharmaceuticals to Present New Data from its Immuno-Oncology Program Using sd-rxRNA Therapeutic Compounds Targeting Intracellular Checkpoint Cbl-b in NK Cells at the 16th Annual Discovery on Targe Sep 26, 2018 08:00AM
RXI Pharma (RXII) Collaboration with BioAxone BioSciences Inc. Secures $1.1M Phase 2 SBIR Funding for Continued Development of sd-rxRNA Drug Candidate Jun 28, 2018 08:12AM
BioAxone BioSciences Awarded $1.1 Million Phase 2 SBIR Funding for Continued Development of sd-rxRNA Drug Candidate for the Treatment of Spinal Cord Injury Jun 28, 2018 08:00AM
BioAxone BioSciences Awarded $1.1 Million Phase 2 SBIR Funding for Continued Development of sd-rxRNA Drug Candidate for the Treatment of Spinal Cord Injury Jun 28, 2018 08:00AM
RXi Pharmaceuticals Corporation Discusses Competitive Advantage, Goals and Milestones for 2016-2017 in New SNNLive Newscast on StockNewsNow.com Nov 28, 2016 08:30AM


Oct 27, 2015 08:30AM StockNewsNow.com Publishes New SNNLive Video Interview with RXi Pharmaceuticals Corporation
Aug 31, 2015 09:25AM Pre-Open Stock Movers 08/31: (VTL) (MDCO) (TWTR) Higher; (ARIA) (AUY) (UTX) Lower (more...)
Aug 7, 2014 10:00AM RXi Pharmaceutical Corporation (NASDAQ: RXII) to Ring The NASDAQ Stock Market Closing Bell